The Department of Pharmaceuticals has directed pharmaceutical companies to submit self-declaration of adherence to the Uniform Code for Pharmaceutical Marketing Practices 2024 (“UCPMP 2024”) in a format (attached), by 30th June, 2024. This declaration, confirming compliance with the UCPMP for the financial year 2024-25, is required to be signed by the executive head of each company, pledging co-operation with authorities for enforcement of UCPMP 2024.
A copy of the Circular is linked below for your ease of reference.
Source: Department of Pharmaceuticals
